Patent details

Basic Information

Publication number:

91411

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP989202544

Legal Status:

Expired

Application number:

91411

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/07/423/001 à 003 -VECTIBIX- Panitumumab

Marketing Authorization Type:

Marketing Authorization Date:

03/12/2007

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Dates

Filing date:

25/01/2008

First Marketing Authorization date:

03/12/2007

Grant date:

25/03/2008

Activation date:

05/05/2018

Publication date:

25/03/2008

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

03/12/2022

SPC Extension Expiration:

03/12/2022

Rejection date:

Withdrawal date:

Owner

From:

25/01/2008

 

 

Name:

Amgen Fremont Inc.

Address:

One Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

25/01/2008

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

JIA Xiao-Chi

Address:

United States (US)

2

Name:

GALLO Michael

Address:

United States (US)

3

Name:

JAKOBOVITS Aya

Address:

United States (US)

4

Name:

YANG Xiao-Dong

Address:

United States (US)

Publication

Bulletin

Bulletin Heading:

SPC3

Bulletin edition number:

2018/07

Publication date:

21/06/2018

Description:

Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

20/04/2022

Last Annual Fee Paid Number:

25

Last Annual Fee Paid Amount:

450 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages